Brief: AB Science: Publication In Science Confirms Potential Of Masitinib As Treatment Of COVID-19

AB Science SA

20/07/2021 17:25

July 20 (Reuters) - AB SCIENCE SA  ABS.PA :
    * AB SCIENCE ANNOUNCES THE PUBLICATION OF AN ARTICLE IN THE
WORLD-RENOWNED JOURNAL SCIENCE THAT CONFIRMS POTENTIAL OF
MASITINIB AS A TREATMENT OF COVID-19 WITH ANTI-VIRAL ACTIVITY
AGAINST SARS-COV-2 AND ALL TESTED VARIANTS OF CONCERN
    * MASITINIB EFFECTIVELY REDUCED SARS-COV-2 VIRAL LOAD IN
VIVO,
REDUCING INFLAMMATORY SIGNATURES, AND SHOWED POTENTIAL BENEFITS
FOR SURVIVAL AND CLINICAL SCORES
    * ALSO REPORTED FOR FIRST TIME ARE DATA ON EFFECTIVENESS OF
MASITINIB AS AN ANTI-SARS-COV-2 DRUG IN ANIMALS
    * MICE INFECTED WITH SARS-COV-2 AND THEN TREATED WITH
MASITINIB
SHOWED >200-FOLD REDUCTION IN VIRAL TITERS IN LUNGS AND NOSE
    * RESULTS SHOWED THAT MASITINIB RAPIDLY AND EFFECTIVELY
REDUCED
SARS-COV-2 VIRAL LOAD IN MICE

Source text for Eikon:  ID:nGNX29MXtt 
Further company coverage:  ABS.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))